STIM Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas

03

Preço $2.16

Capitalização de Mercado (MRQ) $165M

P/E (TTM) -4.9

EPS (TTM) $-0.44

Receita (TTM) $155M

ROE (TTM) -135.3%

Dívida/Capital (MRQ) 3.4

Intervalo 52 Semanas $1–$3

STIM Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização

04

intervalo

barras

A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.

Sobre Neuronetics, Inc. - Common Stock Visão geral da empresa da Wikipedia

05 · wikidata

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.

Neuronetics became the "first and only Food and Drug Administration (FDA) approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device (FDA approval K061053)."

They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head.

Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗

Wikidata ↗

setorHealth Care indústriaHealth Care funcionários658 paísUS

Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS

06

Receita$149M

2016-12-31 → 2025-12-31

EPS$-0.59

2019-12-31 → 2025-12-31

Fluxo de caixa livre$-21M

2018-12-31 → 2025-12-31

Margem líquida-19.6%

2018-12-31 → 2025-12-31

Avaliação e Proporções 07–12

Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?

Métrica	STIM	média 5A	Mediana de Pares	Veredito
P/E (TTM)	-4.9média 5A ≈-3.0	≈-3.0	·	·
P/S (TTM)	1.1média 5A ≈1.6	≈1.6	3.1	Subvalorizado
P/B (MRQ)	9.2média 5A ≈2.9	≈2.9	3.7	Sobreavaliado
EV / EBITDA	-6.7média 5A ≈-3.7	≈-3.7	·	·
Preço / FCF (TTM)	-14.6média 5A ≈-3.8	≈-3.8	·	·
Preço / Fluxo de Caixa (TTM)	-16.0média 5A ≈-4.1	≈-4.1	·	·
EV / Revenue (EV / Receita)	1.3média 5A ≈1.4	≈1.4	·	·
EV / FCF	-8.8média 5A ≈-3.8	≈-3.8	·	·
Preço / Valor Patrimonial Tangível (MRQ)	382.7média 5A ≈2.4	≈2.4	·	·

A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.

Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC

Métrica	STIM	média 5A	Mediana de Pares	Veredito
Margem Bruta (TTM)	49.1%média 5A ≈69.7%	≈69.7%	51.1%	Em linha
Margem Operacional (TTM)	-14.7%média 5A ≈-42.7%	≈-42.7%	0.77%	Abaixo da média
Margem EBITDA (TTM)	-12.7%média 5A ≈-40.3%	≈-40.3%	0.77%	Abaixo da média
Margem de Lucro Líquido (TTM)	-19.6%média 5A ≈-48.0%	≈-48.0%	-2.9%	Fraco
ROA (TTM)	-22.9%média 5A ≈-29.0%	≈-29.0%	-18.1%	Fraco
ROE (TTM)	-135.3%média 5A ≈-104.5%	≈-104.5%	-13.7%	Fraco

Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial

Métrica	STIM	média 5A	Mediana de Pares	Veredito
Dívida / Patrimônio Líquido (MRQ)	3.4média 5A ≈1.5	≈1.5	0.4	Dívida alta
Índice de liquidez corrente (MRQ)	1.9média 5A ≈3.8	≈3.8	2.3	Abaixo da média
Quick Ratio (Índice de Liquidez Seca)	1.5média 5A ≈3.1	≈3.1	1.5	Em linha
Dívida de Longo Prazo / Patrimônio Líquido (MRQ)	3.4média 5A ≈1.5	≈1.5	·	·

Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos

Métrica	STIM	média 5A	Mediana de Pares	Veredito
Revenue YoY (Receita Ano a Ano)	99.2%média 5A ≈28.8%	≈28.8%	·	·
Revenue CAGR 3Y (CAGR Receita 3A)	31.8%média 5A ≈18.5%	≈18.5%	·	·
Revenue CAGR 5Y (CAGR Receita 5A)	24.8%	·	·	·

Métricas por Ação EPS, valor patrimonial por ação, fluxo de caixa por ação, dividendo por ação

Métrica	STIM	média 5A	Mediana de Pares	Veredito
EPS (Diluted) (EPS (Diluído))	$-0.59média 5A ≈$-1.12	≈$-1.12	·	·
Revenue / Share (Receita / Ação)	$2.26média 5A ≈$2.34	≈$2.34	·	·
Cash Flow / Share (Fluxo de Caixa / Ação)	$-0.31média 5A ≈$-0.93	≈$-0.93	·	·
Cash / Share (Caixa / Ação)	$0.41média 5A ≈$1.79	≈$1.79	·	·

Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber

Métrica	STIM	média 5A	Mediana de Pares	Veredito
Asset Turnover (Giro do Ativo)	1.1média 5A ≈0.7	≈0.7	1.1	Em linha
Inventory Turnover (Giro de Estoque)	17.9média 5A ≈5.6	≈5.6	3.5	Primeira linha
Receivables Turnover (Giro de Contas a Receber)	7.5média 5A ≈5.9	≈5.9	6.0	Primeira linha
Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.)	≈$226.7K	·	·	·

valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana

Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados

14

Surpresa Média -11.0%

Próximo relatório Nov 02, 2026

Período	Relatório	EPS Actual	EPS est.	Surpresa
30 de Junho de 2026	Ago 3, 2026	$-0.04	$-0.12	68.0%
31 de Março de 2026	Mai 12, 2026	$-0.15	$-0.18	15.2%
31 de Dezembro de 2025		$-0.10	$-0.11	8.1%
30 de Setembro de 2025		$-0.13	$-0.13	-0.62%
30 de Junho de 2025		$-0.15	$-0.08	-91.8%
31 de Março de 2025		$-0.21	$-0.13	-64.7%

Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa

15

Demonstração de Resultados 16

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue	$149M	$75M	$71M	$65M	$55M	$49M	$63M	$53M	$40M
Cost of Revenue	$77M	$21M	$20M	$15M	$12M	$12M	$15M	$12M	$10M
Gross Profit	$72M	$54M	$52M	$50M	$44M	$38M	$47M	$40M	$31M
R&D Expense	$7M	$13M	$10M	$9M	$8M	$9M	$14M	$8M	$8M
SG&A Expense	$50M	$30M	$25M	$26M	$26M	$18M	$17M	$14M	$9M
Operating Expenses	$104M	$89M	$82M	$85M	$71M	$60M	$74M	$60M	$44M
Operating Income	$-31M	$-35M	$-31M	$-35M	$-28M	$-22M	$-27M	$-20M	$-14M
Interest Expense	·	$7M	$5M	$4M	$4M	$5M	$4M	$4M	$3M
Other Non-op	$716.0K	$3M	$6M	$2M	$390.0K	$302.0K	$2M	$-575.0K	$357.0K
Pretax Income	·	·	·	·	·	·	$-29M	$-24M	$-16M
Net Income	$-39M	$-44M	$-30M	$-37M	$-31M	$-27M	$-29M	$-24M	$-16M
EPS (Basic)	$-0.59	$-1.38	$-1.05	$-1.38	$-1.22	$-1.46	$-1.58	·	·
EPS (Diluted)	$-0.59	$-1.38	$-1.05	$-1.38	$-1.22	$-1.46	$-1.58	·	·
Shares (Basic)	65,951,000	31,734,000	28,658,000	26,900,000	25,479,000	18,835,000	18,380,000	·	·
Shares (Diluted)	65,951,000	31,734,000	28,658,000	26,900,000	25,479,000	18,835,000	18,380,000	·	·
EBITDA	$-28M	$-32M	$-29M	$-33M	$-27M	$-21M	$-26M	$-19M	·

Balanço Patrimonial 24

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	$28M	$18M	$60M	$70M	$94M	$49M	$76M	$105M	$29M
Receivables	$16M	$23M	$16M	$14M	$8M	$7M	$7M	$6M	$4M
Inventory	$4M	$4M	$8M	$9M	$7M	$4M	$3M	$2M	$2M
Prepaid Expense	$3M	$7M	$5M	$2M	$3M	$2M	$2M	$2M	$1M
Current Assets	$62M	$58M	$94M	$99M	$115M	$65M	$88M	$114M	$37M
PP&E (Net)	$4M	$6M	$2M	$2M	$1M	$730.0K	$1M	$1M	$1M
PP&E (Gross)	$9M	$9M	$5M	$5M	$4M	$3M	$3M	$3M	$3M
Accum. Depreciation	$4M	$3M	$3M	$3M	$3M	$2M	$2M	$2M	$2M
Goodwill	$24M	$19M	·	·	·	·	·	·	·
Intangibles	$18M	$20M	·	·	·	·	·	·	·
Other Non-current Assets	$2M	$2M	$4M	$4M	$2M	$2M	$1M	$1M	$574.0K
Total Assets	$142M	$141M	$116M	$117M	$141M	$79M	$100M	$117M	$39M
Accounts Payable	$11M	$11M	$5M	$2M	$4M	$4M	$5M	$4M	$3M
Accrued Liabilities	$12M	$13M	$13M	$15M	$8M	$7M	$9M	$8M	$8M
Current Liabilities	$31M	$31M	$20M	$33M	$16M	$14M	$28M	$14M	$12M
Capital Leases	$19M	$23M	$2M	$3M	$4M	$3M	$3M	·	·
Total Liabilities	$115M	$109M	$82M	$60M	$56M	$53M	$52M	$46M	$44M
Long-term Debt	$66M	$55M	$59M	$36M	$35M	$35M	$31M	$30M	$30M
Total Debt	$66M	$55M	$59M	$36M	$35M	$35M	$31M	$30M	·
Common Stock	$690.0K	$557.0K	$291.0K	$273.0K	$264.0K	$191.0K	$186.0K	$177.0K	$2.0K
Retained Earnings	$-459M	$-420M	$-376M	$-346M	$-309M	$-278M	$-250M	$-221M	$-197M
Stockholders' Equity	$22M	$28M	$34M	$57M	$85M	$25M	$48M	$71M	$-193M
Liabilities + Equity	$142M	$141M	$116M	$117M	$141M	$79M	$100M	$117M	$39M
Shares Outstanding	68,994,000	55,679,000	29,092,000	27,268,000	26,395,000	19,114,000	18,645,000	17,744,000	231,000

Fluxo de Caixa 14

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
D&A	$3M	$2M	$2M	$2M	$1M	$941.0K	$1M	$882.0K	$596.0K
Stock-based Comp	$7M	$6M	$7M	$9M	$8M	$4M	$3M	$2M	$496.0K
Deferred Tax	$0	$0	$0	$0	$0	$0	$0	$0	$0
Amort. of Intangibles	$2M	$100.0K	·	·	·	·	·	·	·
Other Non-cash	$8M	$5M	$-11M	$-4M	$-6M	$-6M	$-6M	$881.0K	·
Operating Cash Flow	$-20M	$-31M	$-32M	$-31M	$-28M	$-28M	$-30M	$-21M	$-11M
CapEx	$801.0K	$1M	$2M	$3M	$2M	$730.0K	$813.0K	$1M	$594.0K
Investing Cash Flow	$-801.0K	$-2M	$-1M	$7M	$-10M	$-730.0K	$-813.0K	$-1M	$-594.0K
Debt Issued	$10M	$57M	$25M	·	·	$41M	·	·	·
Net Debt Issued	$10M	$-3M	$24M	·	·	$2M	·	·	·
Stock Issued	·	·	·	·	$81M	·	·	·	·
Net Stock Activity	·	·	·	·	$81M	·	·	·	·
Financing Cash Flow	$36M	$-7M	$23M	$207.0K	$83M	$2M	$2M	$97M	$24M
Free Cash Flow	$-21M	$-32M	$-34M	$-34M	$-30M	$-29M	$-31M	$-22M	·

Lucratividade 7

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Gross Margin	48.5%	72.3%	72.5%	76.3%	78.9%	·	·	76.4%	·
Operating Margin	-21.1%	-46.2%	-42.8%	-53.8%	-49.8%	·	·	-37.6%	·
Net Margin	-26.2%	-58.4%	-42.3%	-57.0%	-56.4%	·	·	-45.7%	·
Pretax Margin	·	·	·	·	·	·	·	-45.7%	·
EBITDA Margin	-18.8%	-43.4%	-40.0%	-51.3%	-47.9%	·	·	-35.9%	·
ROA	-27.6%	-34.1%	-25.9%	-28.8%	-28.4%	-30.7%	-26.8%	-30.9%	·
ROE	-155.7%	-185.6%	-83.7%	-61.9%	-35.4%	-103.6%	-56.9%	-32.7%	·

Liquidez e Solvência 5

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Current Ratio	2.0	1.9	4.7	3.0	7.3	4.8	3.2	8.4	·
Quick Ratio	1.5	1.3	3.8	2.5	6.5	4.1	3.0	8.1	·
Debt / Equity	2.9	2.0	1.7	0.6	0.4	1.4	0.7	0.4	·
LT Debt / Equity	2.9	2.0	1.7	0.4	0.4	1.4	0.4	0.4	·
Interest Coverage	·	-4.7	-5.6	-8.3	-6.9	-4.9	-7.3	-5.4	·

Eficiência 3

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Asset Turnover	1.1	0.6	0.6	0.5	0.5	·	·	0.7	·
Inventory Turnover	17.9	3.4	2.3	2.0	2.3	3.6	5.9	5.1	·
Receivables Turnover	7.5	3.8	4.9	6.1	7.4	·	·	10.7	·

Por Ação 5

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Book Value / Share	$0.32	$0.50	$1.18	$2.09	$3.23	$1.33	$2.57	$4.00	·
Revenue / Share	$2.26	$2.36	$2.49	$2.42	$2.17	·	·	·	·
Cash Flow / Share	$-0.31	$-0.98	$-1.12	$-1.14	$-1.10	·	·	·	·
Cash / Share	$0.41	$0.33	$2.05	$2.58	$3.57	$2.56	$4.06	$5.89	·
EPS (TTM)	$-0.59	$-1.38	$-1.05	$-1.38	$-1.22	$-1.46	$-1.58	·	·

Taxas de Crescimento 3

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue YoY	99.2%	5.0%	9.4%	17.9%	12.3%	·	·	·	·
Revenue CAGR 3Y	31.8%	10.6%	13.2%	·	·	·	·	·	·
Revenue CAGR 5Y	24.8%	·	·	·	·	·	·	·	·

Avaliação (TTM) 14

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue TTM	$149M	$75M	$71M	$65M	$55M	$49M	$63M	$53M	·
Net Income TTM	$-39M	$-44M	$-30M	$-37M	$-31M	$-27M	$-29M	$-24M	·
Market Cap	$95M	$90M	$84M	$187M	$118M	$212M	$84M	$343M	·
Enterprise Value	$133M	$126M	$84M	$153M	$59M	$198M	$39M	$269M	·
P/E	-2.3	-1.2	-2.8	-5.0	-3.7	-7.6	-2.8	·	·
P/S	0.6	1.2	1.2	2.9	2.1	4.3	1.3	6.5	·
P/B	4.3	3.2	2.5	3.3	1.4	8.3	1.7	4.8	·
P / Tangible Book	·	·	2.5	3.3	1.4	8.3	·	·	·
P / Cash Flow	-4.7	-2.9	-2.6	-6.1	-4.2	-7.5	-2.7	-16.7	·
P / FCF	-4.5	-2.8	-2.5	-5.5	-3.9	-7.3	-2.7	-15.9	·
EV / EBITDA	-4.8	-3.9	-2.9	-4.6	-2.2	-9.3	-1.5	-14.2	·
EV / FCF	-6.3	-3.9	-2.4	-4.5	-1.9	-6.8	-1.3	-12.5	·
EV / Revenue	0.9	1.7	1.2	2.3	1.1	4.0	0.6	5.1	·
Earnings Yield	-42.8%	-85.7%	-36.2%	-20.1%	-27.4%	-13.1%	-35.2%	·	·

Demonstração de Resultados 15

Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$42M	$34M	$42M	$37M	$38M	$32M	$22M	$19M	$16M	$17M	$20M	$18M	$18M	$16M	$18M	$16M
Cost of Revenue	$20M	$18M	$20M	$20M	$20M	$16M	$8M	$5M	$4M	$4M	$5M	$6M	$5M	$4M	$4M	$4M
Gross Profit	$21M	$16M	$22M	$17M	$18M	$16M	$15M	$14M	$12M	$13M	$16M	$12M	$13M	$11M	$14M	$13M
R&D Expense	$1M	$1M	$2M	$2M	$2M	$2M	$6M	$2M	$2M	$2M	$2M	$2M	$2M	$3M	$3M	$2M
SG&A Expense	$11M	$13M	$13M	$11M	$12M	$13M	$11M	$7M	$6M	$6M	$6M	$6M	$6M	$7M	$6M	$6M
Operating Expenses	$23M	$25M	$27M	$24M	$26M	$27M	$26M	$22M	$21M	$20M	$20M	$21M	$20M	$21M	$22M	$20M
Operating Income	$-2M	$-9M	$-5M	$-7M	$-8M	$-11M	$-11M	$-8M	$-9M	$-7M	$-4M	$-9M	$-7M	$-10M	$-8M	$-7M
Interest Expense	$2M	$2M	·	$2M	$2M	$2M	·	$2M	$2M	$2M	·	$1M	$1M	$1M	$1M	$1M
Other Non-op	$162.0K	$1M	$155.0K	$126.0K	$188.0K	$247.0K	$545.0K	$539.0K	$653.0K	$812.0K	$893.0K	$664.0K	$4M	$640.0K	$648.0K	$906.0K
Net Income	$-3M	$-11M	$-7M	$-9M	$-10M	$-13M	$-13M	$-13M	$-10M	$-8M	$-5M	$-9M	$-5M	$-11M	$-8M	$-8M
EPS (Basic)	$-0.05	$-0.16	$-0.10	$-0.13	$-0.15	$-0.21	$-0.34	$-0.44	$-0.33	$-0.27	$-0.17	$-0.33	$-0.17	$-0.38	$-0.30	$-0.28
EPS (Diluted)	$-0.05	$-0.16	$-0.10	$-0.13	$-0.15	$-0.21	$-0.34	$-0.44	$-0.33	$-0.27	$-0.17	$-0.33	$-0.17	$-0.38	$-0.30	$-0.28
Shares (Basic)	73,129,000	69,589,000	·	67,309,000	66,180,000	61,465,000	·	30,267,000	30,052,000	29,472,000	·	28,876,000	28,590,000	28,034,000	·	26,965,000
Shares (Diluted)	73,129,000	69,589,000	·	67,309,000	66,180,000	61,465,000	·	30,267,000	30,052,000	29,472,000	·	28,876,000	28,590,000	28,034,000	·	26,965,000
EBITDA	·	$-8M	·	$-7M	$-8M	$-10M	·	$-8M	$-9M	$-6M	·	$-9M	$-7M	$-9M	·	$-7M

Balanço Patrimonial 25

Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$19M	$13M	$28M	$28M	$11M	$20M	$18M	$21M	$43M	$48M	$60M	$36M	$46M	$55M	$70M	$74M
Receivables	$16M	$16M	$16M	$19M	$26M	$26M	$23M	$17M	$17M	$18M	·	$15M	$13M	$9M	·	$12M
Inventory	$6M	$5M	$4M	$4M	$5M	$4M	$4M	$5M	$6M	$7M	·	$10M	$9M	$9M	·	$9M
Prepaid Expense	$4M	$4M	$3M	$4M	$4M	$5M	$7M	$5M	$4M	$4M	·	$5M	$5M	$2M	·	$3M
Current Assets	$53M	$47M	$62M	$65M	$56M	$61M	$58M	$53M	$76M	$82M	·	$71M	$78M	$81M	·	$101M
PP&E (Net)	$3M	$4M	$4M	$5M	$5M	$6M	$6M	$2M	$2M	$2M	·	$2M	$2M	$2M	·	$2M
PP&E (Gross)	$7M	$8M	$9M	$9M	$9M	$9M	$9M	$5M	$5M	$5M	·	$6M	$5M	$5M	·	$5M
Accum. Depreciation	$4M	$4M	$4M	$4M	$4M	$4M	$3M	$3M	$3M	$3M	·	$4M	$3M	$3M	·	$3M
Goodwill	$24M	$24M	$24M	$23M	$19M	$19M	$19M	·	·	·	·	·	·	·	·	·
Intangibles	$17M	$18M	$18M	$19M	$19M	$19M	$20M	·	·	·	·	·	·	·	·	·
Other Non-current Assets	$3M	$2M	$2M	$2M	$2M	$2M	$2M	$5M	$5M	$5M	·	$4M	$4M	$3M	·	$4M
Total Assets	$132M	$125M	$142M	$145M	$135M	$142M	$141M	$74M	$97M	$104M	·	$93M	$100M	$104M	·	$119M
Accounts Payable	$12M	$11M	$11M	$12M	$10M	$8M	$11M	$3M	$4M	$3M	·	$3M	$4M	$5M	·	$2M
Accrued Liabilities	$9M	$10M	$12M	$10M	$11M	$9M	$13M	$11M	$9M	$9M	·	$10M	$8M	$7M	·	$11M
Current Liabilities	$28M	$28M	$31M	$29M	$28M	$25M	$31M	$17M	$29M	$14M	·	$15M	$15M	$15M	·	$25M
Capital Leases	$20M	$19M	$19M	$19M	$20M	$22M	$23M	$2M	$2M	$2M	·	$3M	$3M	$3M	·	$3M
Other Non-current Liabilities	$142.0K	$71.0K	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Total Liabilities	$110M	$108M	$115M	$114M	$103M	$102M	$109M	$65M	$77M	$76M	·	$55M	$55M	$55M	·	$56M
Long-term Debt	$62M	$61M	$66M	$66M	$56M	$55M	$55M	$46M	$60M	$59M	·	$37M	$37M	$37M	·	$36M
Total Debt	·	$61M	·	$66M	$56M	$55M	·	$46M	$60M	$59M	·	$37M	$37M	$37M	·	$36M
Common Stock	$762.0K	$696.0K	$690.0K	$685.0K	$661.0K	$658.0K	$557.0K	$303.0K	$301.0K	$300.0K	·	$289.0K	$288.0K	$285.0K	·	$270.0K
Retained Earnings	$-473M	$-470M	$-459M	$-452M	$-443M	$-432M	$-420M	$-407M	$-394M	$-384M	·	$-371M	$-361M	$-356M	·	$-338M
Stockholders' Equity	$18M	$13M	$22M	$27M	$27M	$35M	$28M	$9M	$19M	$28M	·	$38M	$45M	$48M	·	$63M
Liabilities + Equity	$132M	$125M	$142M	$145M	$135M	$142M	$141M	$74M	$97M	$104M	·	$93M	$100M	$104M	·	$119M
Shares Outstanding	76,193,000	69,583,000	68,994,000	68,445,000	66,113,000	65,820,000	55,679,000	30,317,000	30,136,000	29,975,000	·	28,902,000	28,813,000	28,465,000	·	27,060,000

Fluxo de Caixa 13

Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$729.0K	$745.0K	$767.0K	$886.0K	$901.0K	$911.0K	$446.0K	$512.0K	$555.0K	$560.0K	$503.0K	$499.0K	$488.0K	$516.0K	$604.0K	$387.0K
Stock-based Comp	$688.0K	$2M	$2M	$1M	$2M	$1M	$1M	$1M	$2M	$1M	$2M	$2M	$2M	$2M	$2M	$2M
Amort. of Intangibles	$400.0K	$400.0K	$300.0K	$400.0K	$400.0K	$400.0K	$100.0K	$0	$0	$0	·	·	·	·	·	·
Other Non-cash	·	$-1M	·	·	·	$-7M	·	·	·	$-6M	·	·	·	$-7M	·	·
Operating Cash Flow	$-1M	$-9M	$908.0K	$-785.0K	$-4M	$-17M	$-9M	$-5M	$-5M	$-12M	$2M	$-10M	$-9M	$-15M	$-3M	$-7M
CapEx	$417.0K	$197.0K	$216.0K	$114.0K	$252.0K	$219.0K	$89.0K	$386.0K	$616.0K	$375.0K	$879.0K	$552.0K	$704.0K	$234.0K	$503.0K	$726.0K
Investing Cash Flow	$-417.0K	$-172.0K	$-216.0K	$-114.0K	$-252.0K	$-219.0K	$-2M	$14.0K	$-119.0K	$68.0K	$-563.0K	$66.0K	$-642.0K	$-183.0K	$-503.0K	$9M
Debt Issued	·	·	$0	·	·	·	$9M	·	·	·	$22M	$0	$0	$2M	·	·
Net Debt Issued	·	$-5M	·	·	·	·	·	·	·	·	·	·	·	$1M	·	·
Stock Issued	·	·	·	·	$0	$21M	·	·	·	·	·	·	·	·	·	·
Net Stock Activity	·	·	·	·	·	$21M	·	·	·	·	·	·	·	·	·	·
Financing Cash Flow	$7M	$-6M	$-1M	$18M	$1.0K	$19M	$10M	·	·	·	$22M	$0	$-62.0K	$499.0K	$245.0K	$0
Free Cash Flow	·	$-10M	·	·	·	$-17M	·	·	·	$-12M	·	·	·	$-15M	·	·

Lucratividade 6

Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Gross Margin	·	46.9%	·	45.9%	46.6%	49.2%	·	75.6%	74.0%	75.1%	·	65.8%	72.5%	73.3%	·	78.4%
Operating Margin	·	-26.1%	·	-19.6%	-21.1%	-34.4%	·	-41.7%	-51.7%	-39.4%	·	-49.6%	-41.7%	-63.7%	·	-45.2%
Net Margin	·	-31.3%	·	-24.2%	-26.6%	-39.6%	·	-72.0%	-59.8%	-45.2%	·	-52.5%	-27.8%	-67.7%	·	-46.1%
EBITDA Margin	·	-23.9%	·	-19.6%	-21.1%	-31.6%	·	-41.7%	-51.7%	-36.2%	·	-49.6%	-41.7%	-60.4%	·	-45.2%
ROA	·	-8.1%	·	-8.2%	-8.7%	-10.3%	·	-16.0%	-10.0%	-7.6%	·	-8.8%	-4.4%	-9.0%	·	-5.8%
ROE	·	-44.3%	·	-49.2%	-43.5%	-40.2%	·	-56.4%	-30.3%	-20.7%	·	-18.6%	-8.6%	-16.8%	·	-9.9%

Liquidez e Solvência 5

Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	·	1.7	·	2.2	2.0	2.4	·	3.2	2.6	5.6	·	4.6	5.2	5.4	·	4.0
Quick Ratio	·	1.0	·	1.6	1.3	1.9	·	2.2	2.0	4.5	·	3.3	3.9	4.3	·	3.4
Debt / Equity	·	4.6	·	2.4	2.0	1.6	·	4.9	3.1	2.1	·	1.0	0.8	0.8	·	0.6
LT Debt / Equity	·	4.6	·	2.4	2.0	1.6	·	4.9	2.4	2.1	·	1.0	0.8	0.8	·	0.4
Interest Coverage	·	-4.0	·	-3.3	-4.1	-5.7	·	-4.5	-4.3	-3.8	·	-7.5	-6.4	-7.9	·	-7.0

Eficiência 3

Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	·	0.3	·	0.3	0.3	0.3	·	0.2	0.2	0.2	·	0.2	0.2	0.1	·	0.1
Inventory Turnover	·	4.2	·	4.4	3.7	3.0	·	0.6	0.6	0.5	·	0.7	0.6	0.5	·	0.5
Receivables Turnover	·	1.6	·	2.1	1.8	1.5	·	1.2	1.1	1.3	·	1.3	1.4	1.8	·	1.7

Por Ação 5

Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	·	$0.19	·	$0.40	$0.41	$0.54	·	$0.31	$0.64	$0.92	·	$1.31	$1.58	$1.70	·	$2.33
Revenue / Share	·	$0.50	·	$0.55	$0.58	$0.52	·	$0.61	$0.55	$0.59	·	$0.62	$0.62	$0.55	·	$0.61
Cash Flow / Share	·	$-0.14	·	·	·	$-0.28	·	·	·	$-0.41	·	·	·	$-0.54	·	·
Cash / Share	·	$0.19	·	$0.41	$0.17	$0.31	·	$0.69	$1.42	$1.59	·	$1.24	$1.59	$1.95	·	$2.72
EPS (TTM)	$-0.49	$-0.54	·	$-0.83	$-1.14	$-1.32	·	$-1.21	$-1.10	$-0.94	·	$-1.18	$-1.13	$-1.35	·	$-1.39

Avaliação (TTM) 11

Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$151M	$152M	·	$130M	$111M	$89M	·	$73M	$72M	$73M	·	$69M	$68M	$67M	·	$62M
Net Income TTM	$-33M	$-37M	·	$-45M	$-49M	$-49M	·	$-36M	$-32M	$-28M	·	$-33M	$-31M	$-37M	·	$-37M
Market Cap	·	$101M	·	$187M	$231M	$242M	·	$23M	$54M	$143M	·	$39M	$62M	$83M	·	$86M
Enterprise Value	·	$149M	·	$225M	$275M	$277M	·	$48M	$71M	$154M	·	$40M	$53M	$64M	·	$48M
P/E	-2.7	-2.7	·	-3.3	-3.1	-2.8	·	-0.6	-1.6	-5.1	·	-1.1	-1.9	-2.2	·	-2.3
P/S	·	0.7	·	1.4	2.1	2.7	·	0.3	0.8	1.9	·	0.6	0.9	1.2	·	1.4
P/B	·	7.6	·	6.8	8.5	6.8	·	2.5	2.8	5.2	·	1.0	1.4	1.7	·	1.4
P / Tangible Book	·	·	·	·	·	·	·	2.5	2.8	5.2	·	1.0	1.4	1.7	·	1.4
P / Cash Flow	·	-10.7	·	·	·	-14.3	·	·	·	-11.9	·	·	·	-5.4	·	·
EV / Revenue	·	1.0	·	1.7	2.5	3.1	·	0.7	1.0	2.1	·	0.6	0.8	1.0	·	0.8
Earnings Yield	-33.9%	-37.2%	·	-30.4%	-32.7%	-35.9%	·	-159.2%	-61.1%	-19.8%	·	-87.4%	-52.6%	-46.4%	·	-43.7%

Período mais recente à esquerda · valores nulos mostrados como ·

Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos

16

Métrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Receita	$149M	$75M	$71M	$65M	$55M
Margem Bruta %	48.5%	72.3%	72.5%	76.3%	78.9%
Margem Operacional %	-21.1%	-46.2%	-42.8%	-53.8%	-49.8%
Lucro líquido	$-39M	$-44M	$-30M	$-37M	$-31M
EPS Diluído	$-0.59	$-1.38	$-1.05	$-1.38	$-1.22

Métrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dívida / Patrimônio Líquido	2.9	2.0	1.7	0.6	0.4
Índice de liquidez corrente	2.0	1.9	4.7	3.0	7.3
Índice de Liquidez Seca	1.5	1.3	3.8	2.5	6.5

Métrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Fluxo de caixa livre	$-21M	$-32M	$-34M	$-34M	$-30M

Investidores institucionais (13F) 99 declarantes · $52.4M total · Em 30 de Junho de 2026

17

Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.

Detentores 99

Valor detido $52.4M

Novas posições 17

Posições encerradas 28

Atividade institucional — Q2 2026 vs trimestre anterior

Novas posições	Posições encerradas	Aumentou	Diminuído	Variação líquida de ações
17 (-12 vs trimestre anterior)	28 (+6 vs trimestre anterior)	30 (+5 vs trimestre anterior)	25 (0 vs trimestre anterior)	-4.3M

Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.

Instituição	Valor	Ações	% de 13F rastreado	Tipo
Madryn Asset Management, LP	$24.102.634	18.540.488	45,99%	Ações
VANGUARD GROUP INC	$3.563.687	2.582.382	6,80%	Ações
UBS Group AG	$2.962.829	2.279.099	5,65%	Ações
WEXFORD CAPITAL LP	$2.603.413	2.002.625	4,97%	Ações
FourWorld Capital Management LLC	$2.267.385	1.744.142	4,33%	Ações
Lane Generational LLC	$2.123.384	1.633.372	4,05%	Ações
VANGUARD CAPITAL MANAGEMENT LLC	$1.959.226	1.507.097	3,74%	Ações
MASTERS CAPITAL MANAGEMENT LLC	$1.300.000	1.000.000	2,48%	Ações
AdvisorShares Investments LLC	$965.634	742.795	1,84%	Ações
Ikarian Capital, LLC	$911.537	701.182	1,74%	Ações
BlackRock, Inc.	$775.608	596.622	1,48%	Ações
HighTower Advisors, LLC	$732.863	563.741	1,40%	Ações
MARSHALL WACE, LLP	$631.400	485.692	1,20%	Ações
GEODE CAPITAL MANAGEMENT, LLC	$596.242	458.474	1,14%	Ações
CITADEL ADVISORS LLC	$548.474	421.903	1,05%	Ações
Dauntless Investment Group, LLC	$479.943	369.187	0,92%	Ações
STATE STREET CORP	$377.389	290.299	0,72%	Ações
Centiva Capital, LP	$371.687	285.913	0,71%	Ações
VANGUARD FIDUCIARY TRUST CO	$344.154	264.734	0,66%	Ações
GOLDMAN SACHS GROUP INC	$343.314	264.088	0,66%	Ações
JBF Capital, Inc.	$303.116	233.166	0,58%	Ações
XTX Topco Ltd	$286.420	220.323	0,55%	Ações
MILLENNIUM MANAGEMENT LLC	$259.285	199.450	0,49%	Ações
BOOTHBAY FUND MANAGEMENT, LLC	$246.042	189.263	0,47%	Ações
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$241.479	185.753	0,46%	Ações
JANE STREET GROUP, LLC	$240.825	185.250	0,46%	Ações
TWO SIGMA ADVISERS, LP	$233.220	169.000	0,44%	Ações
BNP PARIBAS FINANCIAL MARKETS	$193.460	148.815	0,37%	Ações
TUDOR INVESTMENT CORP ET AL	$162.319	124.861	0,31%	Ações
AQR CAPITAL MANAGEMENT LLC	$153.168	117.822	0,29%	Ações
ADAR1 Capital Management, LLC	$130.000	100.000	0,25%	Ações
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$123.767	95.205	0,24%	Ações
Squarepoint Ops LLC	$123.001	94.616	0,23%	Ações
NORTHERN TRUST CORP	$115.880	89.138	0,22%	Ações
WOLVERINE TRADING, LLC	$111.454	41.900	0,21%	Opção de venda
GAMCO INVESTORS, INC. ET AL	$102.960	79.200	0,20%	Ações
Invesco Ltd.	$88.842	68.340	0,17%	Ações
BANK OF AMERICA CORP /DE/	$88.653	68.195	0,17%	Ações
MORGAN STANLEY	$81.762	62.893	0,16%	Ações
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$81.380	62.600	0,16%	Opção de venda
Engineers Gate Manager LP	$74.328	57.175	0,14%	Ações
WOLVERINE TRADING, LLC	$68.096	25.600	0,13%	Opção de compra
VestGen Advisors, LLC	$65.363	50.279	0,12%	Ações
Cruiser Capital Advisors, LLC	$63.570	48.900	0,12%	Ações
Caitong International Asset Management Co., Ltd	$53.716	41.320	0,10%	Ações
Arax Advisory Partners	$51.796	39.843	0,10%	Ações
HSBC HOLDINGS PLC	$49.958	37.847	0,10%	Ações
GABELLI FUNDS LLC	$49.400	38.000	0,09%	Ações
WOLVERINE TRADING, LLC	$43.443	16.332	0,08%	Ações
Quadrature Capital Ltd	$40.113	30.856	0,08%	Ações

Mostrar todos os 99 proprietários institucionais →

Ativistas e proprietários de 5%+ 3 participações

18

Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.

Declarante	Declarado	Participação	Status	Propósito	Declaração
Chernett Jorey ×5 declarações	24 de Agosto de 2026	13,92%	Emenda	·	SEC
MADRYN ASSET MANAGEMENT, LP, MADRYN HEALTH PARTNERS II, LP, MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP, MADRYN HEALTH ADVISORS II, LP, MADRYN HEALTH ADVISORS GP II, LLC, MADRYN SELECT OPPORTUNITIES, LP, MADRYN SELECT ADVISORS, LP, MADRYN SELECT ADVISORS GP, LLC ×3 declarações	4 de Março de 2026	30,30%	Emenda	·	SEC
Cannell Capital LLC, J. Carlo Cannell ×4 declarações	17 de Agosto de 2023	·	Declaração inicial	Investimento passivo	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Executivos da empresa 29 insiders · 9 diretores · 14 conselheiros

19

Investidor com informação privilegiada	Função	Última atividade	Ações detidas	Compras 12m	Vendas 12m	Líquido 12m
Daniel L. Reuvers	President and CEO	23 de Março de 2026 A	1.500.000	0	0	$0
Nir Naor	EVP, CFO & Treasurer	23 de Julho de 2026 A	500.000	0	0	$0
Steven Pfanstiel	Former EVP, CFO and Treasurer	19 de Março de 2026 S	836.643	0	2	$-33.500
Stephen Furlong	EVP, CFO and Treasurer	13 de Maio de 2025 S	410.053	0	0	$0
Peter Donato	Vice President and CFO	14 de Maio de 2019 S	20.987	0	0	$0
William Andrew Macan	EVP, CLO and CS	19 de Março de 2026 S	897.270	0	5	$-55.589
Gregory Harper	VP of Prod. Dev. & Operations	9 de Março de 2021 S	162.554	0	0	$0
Daniel Guthrie	Chief Commercial Officer	22 de Maio de 2020 F	144.180	0	0	$0
Yelena Tropsha	VP of Commercial Access	10 de Março de 2020 F	65.987	0	0	$0
Avinash Amin	Conselheiro	15 de Junho de 2026 J	30.000	0	0	$0
Sasha Cucuz	Conselheiro	28 de Maio de 2026 A	1.542.798	0	0	$0
Megan Rosengarten	Conselheiro	28 de Maio de 2026 A	170.890	0	0	$0
Robert Cascella	Conselheiro	28 de Maio de 2026 A	625.017	0	0	$0
Glenn P Muir	Conselheiro	28 de Maio de 2026 A	401.816	0	0	$0
Joseph H Capper	Conselheiro	25 de Maio de 2023 A	43.147	0	0	$0
JAEGER WILFRED E	Conselheiro	25 de Maio de 2023 A	138.563	0	0	$0
John K Bakewell	Conselheiro	25 de Maio de 2023 A	114.352	0	0	$0
Bruce Joseph Shook	Conselheiro	26 de Maio de 2022 A	68.847	0	0	$0
Brian E Farley	Conselheiro	5 de Agosto de 2020 A	265.748	0	0	$0
Cheryl R Blanchard	Conselheiro	26 de Maio de 2020 A	34.437	0	0	$0
Stephen M Campe	Conselheiro	2 de Janeiro de 2020 A	32.472	0	0	$0
Ronald Hunt	Conselheiro	1 de Abril de 2019 A	847	0	0	$0
Hill Paulina	Conselheiro	2 de Julho de 2018 A	·	0	0	$0
CANNELL CAPITAL LLC	Detentor de 10%	1 de Junho de 2023 J	2.841.223	0	0	$0
Investor Growth Capital, LLC	Detentor de 10%	2 de Julho de 2018 C	1.794.228	0	0	$0
Chernett Jorey	·	13 de Agosto de 2026 S	10.602.988	14	1	$4.809.927
Sheryl L Conley	·	28 de Maio de 2026 A	251.716	0	0	$0
Keith J Sullivan	·	19 de Março de 2026 S	1.590.924	0	4	$-192.798
Christopher Thatcher	·	4 de Março de 2020 M	249.811	0	0	$0

Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto

Participação em ETFs Detido por 4 ETFs

20

O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.

Fundo	Peso	Unidades	Em	Fonte
QQQS · Invesco Exchange-Traded Fund Trust …	0,41%	42.228 SH	2 de Outubro de 2026	Diário
IWC · iShares Trust	0,02%	92.879 SH	11 de Setembro de 2026	Diário
VXF · VANGUARD INDEX FUNDS	0,00%	424.323 SH	19 de Agosto de 2026	Diário
VTI · VANGUARD INDEX FUNDS	0,00%	1.056.478 SH	19 de Agosto de 2026	Diário

STIM Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta

21

classificação · 9 analistas COMPRA

Alvo mediano $5.50 +154,6%

3 33,3% Compra forte

5 55,6% Compra

1 11,1% Manter

0 0,0% Venda

0 0,0% Venda forte

Preço-alvo de 12 meses

4 analistas · 2026-10-03

Alvo médio $5.75 +166,2%

← Abaixo de todos os alvos Preço atual $2.16

Mín$5.00 Média$5.75 Máx$7.00

Comparação de pares (subindústria GICS) Métricas chave vs pares do setor

22

Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.

Ticker	Capitalização de Mercado	P/E	Receita YoY	Margem Líquida	ROE	Margem Bruta
STIM	$95M	-2.3	99.2%	-26.2%	-155.7%	48.5%
PDEX	$187M	14.2	16.4%	17.6%	30.6%	31.4%
KRMD	$269M	-96.8	22.2%	-6.4%	-15.7%	62.3%
HSDT	$126M	-1.6	1057.1%	-679.6%	-26.6%	91.7%
INGN	$183M	-7.8	3.9%	-6.5%	-11.6%	44.2%
OWLT	·	-5.5	35.4%	·	·	·
AGPU	$29M	·	47.7%	-186053.5%	-1012.1%	·
ABT	$250.18B	33.7	5.7%	14.7%	13.1%	·

Últimas notícias Notícias recentes mencionando esta empresa

23

Neuronetics (STIM) Relatório de Resultados do 4º Trimestre de 2025 Yahoo Finance · 6 meses, 2 semanas atrás

Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos

26

Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.

Sua seleção é salva e acompanha você em todos os tickers.

STIM Neuronetics, Inc. - Common Stock